Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Selection of HIV vaccine candidates for concurrent testing in an efficacy trial

Current Opinion in Virology(2016)10.1016/j.coviro.2016.01.007Source: DataRank Database

Selection of HIV vaccine candidates for concurrent testing in an efficacy trial is a research paper published in Current Opinion in Virology (2016). On theSindex it has a DataRank of 0.675. It has been cited 14 times, with 11 citing works in its 1-hop citation network.

N/A

0.675DataRank · unranked

Scored on demand from live citation data

14 citations · 11 citing works in its network

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (10 grants)OA: bronzeTopics (10)IDs (PubMed, PMC)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (0/2)

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 60%Citation Network 40%

Base Score Contribution

0.406

From this paper's citation signal

Citation Network Contribution

0.269

From 10 citing papers with measurable signal

Learn more about DataRank methodology →

Top 5 citers driving the network score

Ranked by each citer's contribution to N(p) — log1p(C_q) divided by its reference count — out of 11 citers.

HIV-1 GP160 (GP120/GP40) Trimer ENV Spike Protein
20184 citations24 referencesContributes 0.067
Combining biomedical preventions for HIV: Vaccines with pre-exposure prophylaxis, microbicides or other HIV preventions
Human Vaccines & Immunotherapeutics201613 citations44 referencesContributes 0.060
HIV-1 Envelope (ENV) GP160 Trimer Protein Complex SPIKE as a Recombinant Macromolecular Assembly Vaccine Component Candidate: Current Opinion
20172 citations26 referencesContributes 0.042
T Cell Immunogenicity, Gene Expression Profile, and Safety of Four Heterologous Prime-Boost Combinations of HIV Vaccine Candidates in Healthy Volunteers: Results of the Randomized Multi-Arm Phase I/II ANRS VRI01 Trial
The Journal of Immunology202210 citations59 referencesContributes 0.041
Human Ig knockin mice to study the development and regulation of HIV‐1 broadly neutralizing antibodies
Immunological Reviews201743 citations151 referencesContributes 0.025

Authors (20)

Carlos DiazGranados,Holly Janes ORCID,Yunda Huang,Allan C deCamp,Barbara Metch

Live enrichment

PubMed:26827165 PMC:PMC4902743

Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.

Grant: W81XWH-11-2-0174

NIH NIAID award

Grant: UM1AI068635

NIAID NIH HHS

Grant: R37 AI054165

NIAID NIH HHS

Grant: UM1 AI068614

NIAID NIH HHS

Grant: UM1 AI068618

NIH HHS

Grant: S10 OD020069

NIAID NIH HHS

Grant: UM1 AI069453

NIGMS NIH HHS

Grant: R01 GM106177

NIAID NIH HHS

Grant: UM1 AI069496

U.S. Department of Defense (DOD)

bronzeLicense: http://www.elsevier.com/open-access/userlicense/1.0/

publisherhttps://www.sciencedirect.com/science/article/am/pii/S1879625716000109

publisherhttps://api.elsevier.com/content/article/PII:S1879625716000109?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1879625716000109?httpAccept=text/plain

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/4902743

MeSH Terms

HumansHIV-1HIV InfectionsAIDS VaccinesImmunization ScheduleData Interpretation, StatisticalAlgorithmsClinical Trials as TopicVaccine PotencyImmunogenicity, Vaccine